Skip to main content

Recap: PETS at ICPE 2022

Faculty and staff from the Center for Pharmacoepidemiology and Treatment Science attended the International Society of Pharmacoepidemiology’s annual conference in Copenhagen, Denmark in August 2022.

ISPE is an international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education and advocacy for the field of pharmacoepidemiology.

PETS at ICPE 2022


Research presentations included:

Tobias Gerhard, BSPharm, PhD, FISPE

Founding Director, Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS)
Interim Director, Rutgers Institute for Health, Health Care Policy and Aging Research
President, International Society of Pharmacoepidemiology

Dr. Gerhard assumed the role as President of ISPE at the conference.

  • Principles of Pharmacoepidemiology
  • Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  • Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
  • Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
  • Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic
  • How Can We Mitigate Publication of Poorly Conducted RWE Studies?

PETS at ICPE 2022

 


Soko Setoguchi, MD, DrPH, FISPE

Core Member, PETS
Professor of Medicine, Director of Clinical Research Education, Director of Clinician Researcher Track, Medicine Residency Program, Department of Medicine, Rutgers Robert Wood Johnson Medical School (RWJMS)
Professor of Epidemiology, Rutgers School of Public Health

  • Practical Skills in Protocol Writing and Statistical Analytic Programming Relevant to Pharmacoepidemiology
  • Data Sourced Heterogeneity in Multi-Data Base Pharmacoepidemiologic Studies: An ISPE-Sponsored Scoping Review
  • Representing and Leveraging Heterogeneity Between Data Sources in Multi-Database Pharmacoepidemiologic Studies
  • Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
  • Claims-Based Algorithm to Define Breast Cancer Recurrence in SEER-Medicare Data
  • Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
  • Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

 


Farzin Khosrow-Khavar, PhD

Core Member, PETS
Instructor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health

  • Aromatase Inhibitors and the Risk of Parkinson’s Disease: Population-Based Cohort Study

 


Elizabeth Suarez, PhD, MPH

Core Member, PETS
Instructor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health

  • Neonatal and Maternal Adverse Outcomes Following Use of Buprenorphine and Methadone for Treatment of Opioid Use Disorder in Pregnancy
  • Psychostimulant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

PETS at ICPE 2022

 


Daniel Horton, MD, MSCE

Core Member, PETS
Assistant Professor, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School
Dr. Horton was awarded a special ISPE award for contributions to public health associated with the COVID-19 pandemic.

  • Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  • Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
  • Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic

 

PETS at ICPE 2022

 


Brian L. Strom, MD, MPH

Chancellor at Rutgers Biomedical and Health Sciences
Editor-in-Chief, Pharmacoepidemiology and Drug Safety

  • Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  • Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

 

PETS at ICPE 2022

 


Chintan Dave, PharmD, PhD

Core Member, PETS
Assistant Professor of Pharmacy, Rutgers Ernest Mario School of Pharmacy

  • Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020

Cardiovascular Outcomes in Patients with Type 2 Diabetes Who Added Either GLP1 Receptor Agonists or DDP4 Inhibitors to SGLT2 Inhibitor Therapy

 

PETS at ICPE 2022

 


Cecilia Huang

Research Project Manager and Senior Data Analyst, Institute for Health, Health Care Policy and Aging Research

  • Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  • Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

 


Stephen Crystal, PhD

Director, Rutgers Center for Health Services Research
Board of Governors Professor of Health Services Research, Rutgers University

  • Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  • Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US

 


Greta Bushnell, PhD, MSPH

Core Member, PETS
Assistant Professor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health

  • Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic

 


Benjamin Bates, MD

Core Member, PETS
Instructor, Rutgers-RWJMS Department of Medicine

  • Claims-Based Algorithm to Define Breast Cancer Recurrence in SEER-Medicare Data
  • Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
  • Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

 


Yola Moride, PhD, FISPE

Research Professor, PETS

  • Pharmacoepidemiologists’ Toolbox for Professional Empowerment
  • Impact of the COVID-19 Pandemic on Drug Safety Surveillance: An Analysis of the Canadian Spontaneous Reporting Database
  • Should We Worry About Flare-Ups Following Vaccination in Systematic Lupus Patients? A Nationwide Case-Crossover Study Using the French Healthcare Database
  • Vaccination and Acute Flares in Rheumatoid Arthritis: A Nationwide Case-Crossover Study Using the French SNDS Health Care Databases
  • Does Hydroxychloroquine Prevent Cardiovascular Events in Systematic Lupus Erythematosus Patients?

 


Julia Liaw

PETS Trainee
PharmD Candidate, Rutgers Ernest Mario School of Pharmacy

  • Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020

PETS at ICPE 2022

 

 

  • Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022

 

Aayush Visaria

  • Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022

 

Garima Mittal

  • Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

 

Mackenzie Henderson

  • Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

 

Haoqian Chen

  • Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

 

Tania J. Atanassova

  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

 

Joanna Madej

  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

 

Sarah McGuire

  • Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

 

See all photos from event: https://www.flickr.com/photos/196557008@N08/albums/72177720302069134/page2